🔎 Trials Near Me

Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Michigan › Ann Arbor

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Ann Arbor, MI

12 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Menerima pesertaFase 2/3
  • University of Michigan (Site # 161), Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Menerima pesertaFase 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06589804

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Menerima pesertaFase 3
  • Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Menerima pesertaFase 1/2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06385080

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Menerima pesertaFase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
  • dan 5 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Menerima pesertaFase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
  • dan 6 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Menerima pesertaFase 2/3
  • University of Michigan Rogel Cancer Center, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04333537

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

Menerima pesertaFase 2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07121595

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Menerima pesertaFase 1
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT04777994

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Menerima pesertaFase 2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT05894083

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Menerima pesertaFase 1/2
  • University of Michigan, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT05902988

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Michigan, Ann Arbor
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT05941507

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di kota lain

Studi lain di Ann Arbor

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.